Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julianna Deakyne

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ACS Medicinal Chemistry Letters|July 14, 2026
Design and Optimization of Benzoic Acid Inhibitors Targeting the EBNA1 DNA-Binding InterfaceGarry R Smith, Mark E McDonnell, Yan Zhang, et al.
SLAS Discovery : Advancing Life Sciences R & D|June 5, 2020
Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug DiscoveryJason E Ekert, Julianna Deakyne, Philippa Pribul-Allen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 18, 2023
CardioMotion: identification of functional and structural cardiotoxic liabilities in small molecules through brightfield kinetic imagingWilliam Stebbeds, Kavita Raniga, David Standing, et al.
Science Translational Medicine|December 13, 2023
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc<sub>1</sub>Stéphanie Braillard, Martine Keenan, Karen J Breese, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ACS Medicinal Chemistry Letters|July 14, 2026
Design and Optimization of Benzoic Acid Inhibitors Targeting the EBNA1 DNA-Binding InterfaceGarry R Smith, Mark E McDonnell, Yan Zhang, et al.
SLAS Discovery : Advancing Life Sciences R & D|June 5, 2020
Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug DiscoveryJason E Ekert, Julianna Deakyne, Philippa Pribul-Allen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 18, 2023
CardioMotion: identification of functional and structural cardiotoxic liabilities in small molecules through brightfield kinetic imagingWilliam Stebbeds, Kavita Raniga, David Standing, et al.
Science Translational Medicine|December 13, 2023
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc<sub>1</sub>Stéphanie Braillard, Martine Keenan, Karen J Breese, et al.
Pageof 1